JDD November 2024 Issue Highlights | Special Focus: Lasers, Light Sources, and Devices
The November Journal of Drugs in Dermatology Editor’s Picks spotlight the dynamic intersection of Lasers, Light Sources, and Devices in dermatology, featuring a mix of insightful studies and discussions. This month’s selections include an intriguing national survey capturing over 190 dermatologists’ perspectives on the role of AI chatbots in dermatology, examining the potential applications, benefits, …
Case Series of Acral and Mucosal Melanoma in a Diverse Patient Population
INTRODUCTION Melanoma accounts for only 1% of all skin cancers but is responsible for most skin cancer-related deaths.1 Acral and mucosal melanoma (AMM) accounts for only 4% of all new melanomas but is associated with poorer prognosis.2 Patients of color are disproportionately affected by AMM. Elucidating the clinical, genetic, and environmental features of AMM can guide advancements …
Continue reading “Case Series of Acral and Mucosal Melanoma in a Diverse Patient Population”
JDD October 2024 Issue Highlights | Special Focus: Atopic Dermatitis
October’s Journal of Drugs in Dermatology Editor’s Picks offer an exciting look into cutting-edge research, with a special focus on atopic dermatitis and several related skin conditions. This month’s selections dive deep into groundbreaking studies, ranging from innovative treatments for acne and environmental skin aging to advancements in hyperhidrosis research using machine learning models. Notably, …
Continue reading “JDD October 2024 Issue Highlights | Special Focus: Atopic Dermatitis”
JDD Buzz Series | Algorithmic Beauty
A study in the September Journal of Drugs in Dermatology addressed the impact of social media algorithms on the perception of beauty. While the golden ratio dates back to ancient Greece – and is an ages-old beauty standard for those of European ancestry – beauty ideals of facial features often change over time and vary …
Inverse Eruptive Syringoma in a Skin of Color Patient
Syringomas are benign neoplasms derived from eccrine sweat glands. Eruptive syringomas are a subtype of syringomas and are typically located on the chest, neck, and abdomen during puberty or childhood. Herein, JDD authors Jennifer Wang BA, Nyousha Yousefi MD, Edward Heilman MD FAAD FCAP, and Jared Jagdeo MD MS present a 20-year-old African American female …
Continue reading “Inverse Eruptive Syringoma in a Skin of Color Patient”
JDD September 2024 Issue Highlights
The September edition of the Journal of Drugs in Dermatology (JDD) focuses on aesthetic treatments, exploring the latest advancements and innovative approaches that are reshaping dermatologic care. This month’s Editor’s Picks bring together a selection of cutting-edge research, from the use of genomic analysis in melanoma management to AI’s influence on beauty standards. Explore the …
JDD Buzz Series | The Burden of Melasma
A study in the August Journal of Drugs in Dermatology addressed the burden of melasma – the populations most prone to melasma and the comorbidities associated with it. According to the study’s authors, a deeper understanding of the associations of race, ethnicity and comorbidities can help dermatologists determine which patients are at risk of developing …
Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was FDA-approved in 2017 for treatment of type II diabetes and in 2021 for treatment for chronic weight management in adults with obesity or overweight with at least one weight-related condition.1 Due to its longer duration of action, it is typically administered subcutaneously once weekly. The safety …
Continue reading “Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports”
JDD Buzz Series | DermTok: Who’s Talking Sun?
TikTok is a source of beauty and skin health information for the masses. Yet much of the content is not produced by board-certified dermatologists or even other healthcare professionals. So who’s creating TikTok content about sun protection and skin cancer? Does any of this content address skin of color? Those are the questions a new …
Continue reading “JDD Buzz Series | DermTok: Who’s Talking Sun?”
JDD August 2024 Issue Highlights
In the August edition of the Journal of Drugs in Dermatology (JDD), we turn our focus to psoriasis, one of the most challenging and impactful dermatological conditions. This month’s Editor’s Picks showcase a series of in-depth studies and expert discussions that explore the latest advancements in psoriasis treatment, real-world effectiveness, and the broader implications of …